Meta-regression of 28 studies of dupilumab in atopic dermatitis (6,542 patients): Southern Europeans had 15.33% greater EASI reduction than East Asians and 10.2% more than Northern/Central Europeans; adverse events were most frequent in Northern/Central Europeans.
Meta-analysisn = 6,542
De Vriese et al. Geographic Differences in Dupilumab Treatment Outcomes for Atopic Dermatitis: A Systematic Review and Meta-Regression Analysis